Medical Research
(H99)
990 on File
PHARE BIO INC
Financial strength (30%)
88/100
Reliability (20%)
45/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$2.1M
Total Revenue
$1.5M
Total Expenses
$2.5M
Net Assets
3
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
75.1%
Fundraising Efficiency
N/A
Operating Reserve
20.61x
Liability-to-Asset
3.0%
Revenue Diversification
99.4%
Executive Compensation
$589K
Compared with Peers
FY 2024
Compared with 332 similar organizations
(United States, Medical Research, $1M–$10M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
75.1% | 83.0% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
24.6% | 10.7% |
P10P90
|
Bottom quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.3% | 2.0% |
P10P90
|
Above median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
20.6 mo | 12.8 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
3.0% | 10.1% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
99.4% | 90.7% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
6.9% | 12.5% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
16.9% | 11.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
32.0% | 2.9% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $2.1M | $1.5M | $2.5M | 75.1% | 3 |
| 2023 | $2.0M | $1.2M | $1.7M | 72.1% | 3 |
| 2022 | $1.6M | $1.2M | $984K | 79.5% | 2 |
| 2019 | $0 | $0 | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.